1,624
Views
13
CrossRef citations to date
0
Altmetric
Study Design Articles

The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomized trial

, , , , , , & show all
Article: 31543 | Received 07 Mar 2016, Accepted 21 May 2016, Published online: 27 Jun 2016

References

  • World Health Organization. Global tuberculosis control 2015. 2015; Geneva: WHO.
  • Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001; 15: 143–52.
  • Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, etal. The HIV-associated tuberculosis epidemic – when will we act?. Lancet. 2010; 375: 1906–19.
  • Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009; 30: 685–99, viii.
  • Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006; 20: 1605–12.
  • Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, etal. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011; 365: 1492–501.
  • Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, etal. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011; 365: 1471–81.
  • Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, etal. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011; 365: 1482–91.
  • World Health Organization. Treatment of tuberculosis: guidelines. 2010; Geneva: WHO. 4th ed.
  • Huerga H, Spillane H, Guerrero W, Odongo A, Varaine F. Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. Int J Tuberc Lung Dis. 2010; 14: 611–15.
  • Lawn SD, Campbell L, Kaplan R, Little F, Morrow C, Wood R, etal. Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township. BMC Infect Dis. 2011; 11: 258.
  • Murphy RA, Sunpath H, Taha B, Kappagoda S, Maphasa KT, Kuritzkes DR, etal. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2010; 14: 903–8.
  • Njozing NB, Miguel SS, Tih PM, Hurtig AK. Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon. BMC Public Health. 2010; 10: 129.
  • van Lettow M, Chan AK, Ginsburg AS, Tweya H, Gareta D, Njala J, etal. Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in Malawi. Public Health Action. 2011; 1: 6–9.
  • Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, Phillips M, etal. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One. 2006; 1: e121.
  • Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low- and middle-income countries: systematic review and meta-analysis 2008–2013. J Acquir Immune Defic Syndr. 2015; 69: 98–108.
  • Dong K, Thabethe Z, Hurtado R, Sibaya T, Dlwati H, Walker B, etal. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa. J Infect Dis. 2007; 196(Suppl 3): S491–6.
  • Gandhi NR, Moll AP, Lalloo U, Pawinski R, Zeller K, Moodley P, etal. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study. J Acquir Immune Defic Syndr. 2009; 50: 37–43.
  • Chileshe M, Bond VA. Barriers and outcomes: TB patients co-infected with HIV accessing antiretroviral therapy in rural Zambia. AIDS Care. 2010; 22(Suppl 1): 51–9.
  • Harris JB, Hatwiinda SM, Randels KM, Chi BH, Kancheya NG, Jham MA, etal. Early lessons from the integration of tuberculosis and HIV services in primary care centers in Lusaka, Zambia. Int J Tuberc Lung Dis. 2008; 12: 773–9.
  • Kumwenda M, Tom S, Chan AK, Mwinjiwa E, Sodhi S, Joshua M, etal. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi. Int J Tuberc Lung Dis. 2011; 15: 1663–9.
  • Lawn SD, Torok ME, Wood R. Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections. Curr Opin Infect Dis. 2011; 24: 34–42.
  • Okot-Chono R, Mugisha F, Adatu F, Madraa E, Dlodlo R, Fujiwara P. Health system barriers affecting the implementation of collaborative TB-HIV services in Uganda. Int J Tuberc Lung Dis. 2009; 13: 955–61.
  • Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr. 2011; 56: 199–203.
  • Joint United States Programme on HIV/AIDS. The GAP report. 2014; Geneva: UNAIDS.
  • World Health Organization. Global tuberculosis control 2013. 2013; Geneva: WHO.
  • The World Bank. Data: Lesotho. 2016. Available from: http://data.worldbank.org/country/lesotho [cited 20 January 2016].
  • Glasgow RE, Eckstein ET, Elzarrad MK. Implementation science perspectives and opportunities for HIV/AIDS research: integrating science, practice, and policy. J Acquir Immune Defic Syndr. 2013; 63(Suppl 1): S26–31.
  • Lesotho Ministry of Health. Kingdom of Lesotho. National Tuberculosis Programme Policy and Manual. Maseru: Lesotho Ministry of Health; 2007.
  • Patton MQ. Qualitative research and evaluation methods. 2002; Thousand Oaks, CA: Sage. 3rd ed.
  • Sandelowski M. Sample size in qualitative research. Res Nurs Health. 1995; 18: 179–83.
  • Ministry of Health and Social Welfare (Lesotho), ICF Macro. Lesotho demographic and health survey 2009. 2010; Maseru, Lesotho: MOHSW.
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606–13.
  • Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption – II. Addiction. 1993; 88: 791–804.
  • Reynolds WM. Development of reliable and valid short forms of the Marlowe-Crowne Social Desirability Scale. J Clin Psychol. 1982; 38: 119–25.
  • Wilson IB, Fowler FJ Jr, Cosenza CA, Michaud J, Bentkover J, Rana A, etal. Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS Behav. 2014; 18: 2349–58.
  • Kalichman SC, Amaral CM, Stearns H, White D, Flanagan J, Pope H, etal. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007; 22: 1003–6.
  • Rubin HJ, Rubin IS. Qualitative interviewing: the art of hearing data. 2004; Thousand Oaks, CA: Sage. 2nd ed.
  • Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008; 41: 327–50.
  • World Health Organization. Compendium of indicators for monitoring and evaluating national tuberculosis programs. 2004; Geneva: WHO.
  • Seale C, Gobo G, Gubrium JF, Silverman D. Qualitative research practice. 2004; Thousand Oaks, CA: Sage.
  • World Health Organization. Global tuberculosis control 2011. 2011; Geneva: WHO.
  • Murray DM, Varnell SP, Blitstein JL. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health. 2004; 94: 423–32.
  • Corbin JM, Strauss A. Grounded theory research: procedures, canons, and evaluative criteria. Qual Sociol. 1990; 13: 3–21.
  • Patton MQ. Enhancing the quality and credibility of qualitative analysis. Health Serv Res (5Pt 2). 1999; 34: 1189–208.
  • United States Agency for International Development. ADS chapter 579: USAID development data. Available from: https://www.usaid.gov/ads/policy/500/579 [cited 6 May 2016]..
  • Duflo E, Kremer M. Use of randomization in the evaluation of development effectiveness. World Bank Operations Evaluation Department Conference on Evaluation and Development Effectiveness. 2003. Available from: http://people.bu.edu/jgerring/Conference/MethodsGovernance/documents/DufloKremerprogrameval.pdf [cited 30 January 2011]..
  • Creswell JW, Plano-Clark VL. Designing and conducting mixed methods research. 2011; Los Angeles, CA: Sage.
  • Greene JC, Caracelli VJ, Graham WF. Toward a conceptual framework for mixed-method evaluation designs. Educ Eval Policy Anal. 1989; 11: 255–74.